Journal of Diabetes Medication & Care

Gestational Diabetes Online Journals

 Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance of different severity with onset or first recognition during pregnancy (Metzger and Counstan, 1998). Gestational diabetes affects 2-10% of pregnancies (Crowther et al., 2005). It usually manifests itself in the latter half of pregnancy and is characterized by carbohydrate intolerance of variable severity (Georgiou et al., 2008). GDM isn't only associated with increasing pregnancy morbidity but also with the increasing possibility for subsequent diabetes in the mother. It is proven that the prevalence of GDM is proportional to the frequency of Type 2 diabetes within a given population (American College of obstetricians and gynaecologists, 2001) GDM is characterized by insulin levels that are insufficient to satisfy insulin demands. There are three general causes which will cause GDM autoimmune β-cell dysfunction, highly penetrant genetic abnormalities that lead to impaired insulin secretion, and 3) β-cell dysfunction that's related to chronic insulin resistance (Metzger and Counstan, 1998). It was proven that the proper identification and management of GDM are related to a decrease in mortality and morbidity in infants. With appropriate therapy, the likelihood of intrauterine fetal death is not detectably above within the general population (Metzger Counstan, 1998). The on time treatment of GDM results in reduction of serious perinatal morbidity and also to improvement of mother’s quality of life. The goal of treatment is to scale back the risks of GDM for mother and child by keeping blood glucose levels equal to those of pregnant women who don't have such a disease.

High Impact List of Articles

Relevant Topics in Material Science